Clinical Studies Pradaxa

Pharmacotherapy Update 2012 - Home Page > The American ...
Citalopram clinical studies – Doses ranged from . 5-60 mg per day – Caused small reduction in heart rate (≤ 8 bpm) – No significant effects on QTc intervals . Celexa® [package insert]. St. Louis, MO. Pradaxa ® prescriptions were ... Fetch Doc

HIGHLIGHTS OF PRESCRIBING INFORMATION There Have Been No ...
There have been no clinical studies establishing conclusive ev idence of macrovascular risk reduction with TRADJENTA tablets or any other antidiabetic drug. 6 ADVERSE REACTIONS 6.1 Clinical Trials Experience ... Read Document

PowerPoint Presentation
Principle’ Direct inhibition of thrombin using a fixed-dose oral medication without routine monitoring is feasible Clinical studies that included about 30,000 patients toxicity based on available clinical data Pradaxa® clinical trial programme RE-MODEL ... Access Full Source

About Experts Sitemap - Group 25 - Page 68 2012-08-30
Three recent studies suggest that PVCs increase risk of heart attack or sudden AFib, anticoagulants: I m not expert enough in Pradaxa in people with impaired kidneys to satisfactorily This type of information needs to be correlated with other clinical information, such as other ... Read Article

Anticoagulant/Anti-Platelet Therapy: The New Kids On The ...
Clinical Pharmacy Specialist single events may be represented in more than one row * Modified factor xa assays are being investigated * Pradaxa Cannot be given PT * 1 less step to activation than clopidogrel * Efficacy and safety data have not been established in prospective studies. ... View Full Source

PRADAXA®(DABIGATRAN ETEXILATE) PRESCRIBER GUIDE FOR STROKE ...
PRADAXA®(DABIGATRAN ETEXILATE) PRESCRIBER GUIDE FOR STROKE PREVENTION IN ATRIAL FIBRILLATION . dabigatran can be dialysed; there is limited clinical experience to demonstrate the utility of this approach in clinical studies. ... Visit Document

Dabigatran (Pradaxa) Guidelines - HealthPartners - Home
Is no clinical experience with this dose and it should be used with caution. Monitoring and laboratory studies Baseline labs: CBC, Platelets, LFTs, SCr, INR & aPTT and start Pradaxa when the international normalized ratio (INR) ... Retrieve Document

Treatment With Pradaxa® Associated With Better Patient Outcomes After A Major Bleeding Event Compared To Warfarin
INGELHEIM, Germany--(BUSINESS WIRE)--For Non-US, Non-UK & Non-Canadian Media Only Results from a new post-hoc analysis of the landmark RE-LY®i trial show that in patients experiencing a major bleeding event, treatment with Pradaxa® (dabigatran etexilate) was associated with lower mortality and a shorter length of stay in intensive care compared to warfarin. In a pooled post-hoc analysis of five ... Read News

Assess Risk Of Bleeding By HAS-BLED Score, (1 Each)
Standing order for pts on Pradaxa: Update in hospital medicine: Studies likely to affect inpatient practice in 2011. Cleveland Clinic Journal of Medicine, 78 (7), pp. 430-434. Shah, S.V., MD., et al. (2011). Cost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillation. ... View Doc

Stroke - Wikipedia, The Free Encyclopedia
The diagnosis of stroke itself is clinical, with assistance from the imaging techniques. Imaging techniques also assist in determining the subtypes and cause of stroke. various other studies may be performed to determine the underlying cause. ... Read Article

New Sub-Analyses Report Pradaxa® (dabigatran Etexilate Mesylate) May Be Associated With Better Patient Outcomes After ...
RIDGEFIELD, Conn., Dec. 8, 2012 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced results from two new post-hoc sub-analyses comparing the clinical management and outcomes of patients ... Read News

Www.pbm.va.gov
(Pradaxa®) Criteria for Use. December 2011. Though pharmacokinetic studies indicated some reduction in dabigatran exposure when dabigatran is co-administered with proton pump inhibitors The clinical implications of this finding are unclear. ... View Doc

WILL NEXT GENERATION ORAL ANTICOAGULANTS REPLACE WARFARIN AS ...
Pradaxa: With first mover advantage, Will it be the Leader in SPAF? Xarelto: Is it the future mainstay anticoagulant therapy? Ongoing clinical studies Xarelto – Review of MAGELLAN study Semuloparin - Clinical data comparison Of VTE ... Retrieve Full Source

GENERICS IN THE PIPELINE, 2011-2012 - HealthTrans ...
Pradaxa dabigatran etexilate Boehringer Ingelheim Prevention of stroke in atrial fibrillation October 19, 2010 High established in two clinical studies in which vilazodone was shown to be superior to placebo in improving symptoms of ... Return Document

Red Yeast Rice - What You Need To Know
There have only been a few well-designed studies on red yeast rice in humans. American Journal of Clinical Nutrition. 69.2 (1999):231-6. Monograph. Monascus purpureus (red yeast rice). Alternative Medicine Review. 9.2 (2004):208-10. ... Read Article

Focus On Clinical Research NOPQ
Clinical Activities at Boehringer Ingelheim in Numbers During the past decade from 2000 to 2009, Boehringer Ingelheim conducted or sponsored 1,296 studies with 112 substances in 84 countries from all regions of the world. pradaxa® vs.placebo, 1,800 patients Secondary prevention of venous ... Read Document

New Drugs 2010 Final
Received Silenor in controlled clinical studies. • No overall differences in safety or effectiveness were observed between these subjects and younger adult Dabigatran (Pradaxa®) Clinical Trials: Re-COVER • Noninferiority RCT, DB (N=2539) ... Fetch Document

Reversing Rivaroxaban & Dabigatran - YouTube
Clinical studies on the prevention and treatment of venous and arterial thromboembolism show promising results for rivaroxaban and dabigatran. Peter C. Block, MD, FACC 9:55 Pradaxa (dabigatran) approval by greatdoctorstv 3,852 views; ... View Video

(DABIGATRAN ETEXILATE) PRESCRIBER GUIDE - Shared Care ...
PRADAXA ® (DABIGATRAN there is limited clinical experience to demonstrate the utility of this approach in clinical studies. In the event of haemorrhagic complications, treatment must be discontinued and the source of bleeding investigated. Since ... Read Here

Evolution Of Anticoagulation - Butler University
Discuss significant clinical studies with new agents. Discuss likely place in therapy for new agents. Evolution of Anticoagulation. 1930s Heparin. 1950s . Warfarin. www.pradaxa.com. Dabigatran. Dosing in renal impairment. ClCr 30-50ml/min – 150mg/day. ... Fetch Full Source

I]gdbWdZbWda^X 9^hZVhZ 8a^c^XVa Ig^Vah - Welcome To Pradaxa
Etexilate is in clinical development and not licensed for clinical use in the following The re-VoLuTioN® trial programme encompasses studies in primary VTe prevention, acute VTe treatment, secondary VTe Pradaxa ® (dabigatran ... Access Document

Clinical Pearls For Students - American Society Of Health ...
Clinical Pearls for Students (Pradaxa®) • Approved in early Studies / Theoretical: •Prothrombin Complex Concentrate (PCC) ?? •Hemodialysis •Pheresis •Factor VIIa •Desmopressin Studies ... Access Doc